ferrous sulfate has been researched along with Colitis Gravis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gasche, C; Iqbal, T; Kulnigg-Dabsch, S; Sharma, N; Stein, J; Vel, S | 1 |
| Algaba, A; Bermejo, F; Carneros, JA; de la Morena, F; Gisbert, JP; González-Lama, Y; Mancenido, N; Maté, J; McNicholl, AG; Pajares, R; Pérez-Calle, JL; Rodríguez, M | 1 |
| D'Haens, G; Dudar, LV; Garcia, LC; Gasche, C; Karnafel, W; Kulnigg, S; Sambuelli, AM; Simanenkov, V; Stoinov, S | 1 |
| Altin, M; Demirtürk, L; Hülagü, S; Ozel, M; Yaylaci, M | 1 |
| Hamamoto, T; Kasajima, Y; Kawai, M; Sumimoto, S | 1 |
| Chan, SW; Eveson, J; Prime, SS; Scully, C | 1 |
1 trial(s) available for ferrous sulfate and Colitis Gravis
| Article | Year |
|---|---|
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
Topics: Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Germany; Hemoglobinometry; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged | 2008 |
5 other study(ies) available for ferrous sulfate and Colitis Gravis
| Article | Year |
|---|---|
Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Clinical Trials, Phase III as Topic; Colitis, Ulcerative; Crohn Disease; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Inflammation Mediators; Interleukin-6; Maltose; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Treatment Outcome | 2015 |
Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Female; Ferrous Compounds; Hemoglobins; Humans; Injections, Intravenous; Male; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2009 |
Serum erythropoietin levels in patients with severe anemia secondary to inflammatory bowel disease and the use of recombinant human erythropoietin in patients with anemia refractory to treatment.
Topics: Administration, Oral; Anemia; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Erythropoietin; Ferrous Compounds; Humans; Inflammatory Bowel Diseases; Injections, Subcutaneous; Recombinant Proteins | 1995 |
A case of ulcerative colitis induced by oral ferrous sulfate.
Topics: Administration, Oral; Adolescent; Colitis, Ulcerative; Colon; Delayed-Action Preparations; Female; Ferrous Compounds; Humans | 1992 |
Pyostomatitis vegetans: oral manifestation of ulcerative colitis.
Topics: Acantholysis; Adolescent; Adult; Betamethasone; Colitis, Ulcerative; Female; Ferrous Compounds; Humans; Male; Stomatitis; Sulfasalazine; Tetracycline; Ulcer | 1991 |